Metraipolis › archive › dc_8a6ac415bd81

Drug-resistant tuberculosis and pulmonary co-infections in immunocompromised patients: from multi-omics to precision therapy — Europe PMC PMID:42614800

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42614800
DOI
10.3389/fmicb.2026.1893416
License (as archived)
solo-consultazione
Archived
2026-10-17T04:27:13.323Z
SHA-256 of the archived text
5127c22dbb47ac3f8b9cd4d6f72739a8623eac392b4eef622b939ea8a3c72b47
Stable URL of this page
https://metraipolis.com/documento/dc_8a6ac415bd81

How to cite

Drug-resistant tuberculosis and pulmonary co-infections in immunocompromised patients: from multi-omics to precision therapy — Europe PMC PMID:42614800 — Europe PMC (en), https://europepmc.org/article/MED/42614800 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a6ac415bd81 (Metraipolis archive dc_8a6ac415bd81, sha256 5127c22dbb47ac3f8b9cd4d6f72739a8623eac392b4eef622b939ea8a3c72b47)
BibTeX
@misc{dc8a6ac415bd81,
  title = {Drug-resistant tuberculosis and pulmonary co-infections in immunocompromised patients: from multi-omics to precision therapy — Europe PMC PMID:42614800},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42614800},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a6ac415bd81; sha256 5127c22dbb47ac3f8b9cd4d6f72739a8623eac392b4eef622b939ea8a3c72b47},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42614800. Agents can read the archived copy with the MCP tool read_document.